Group II phospholipase A2 as an autocrine growth factor mediating interleukin-1 action on mesangial cells

Author(s):  
Akira Wada ◽  
Hiromasa Tojo ◽  
Toshihiro Sugiura ◽  
Yoshihiro Fujiwara ◽  
Takenobu Kamada ◽  
...  
1996 ◽  
Vol 315 (2) ◽  
pp. 435-441 ◽  
Author(s):  
Margriet J. B. M. VERVOORDELDONK ◽  
Casper G. SCHALKWIJK ◽  
Josef PFEILSCHIFTER ◽  
Henk van den BOSCH

The expression of 14 kDa group II phospholipase A2 [also referred to as secretory PLA2 (sPLA2)] is induced in rat glomerular mesangial cells by exposure to inflammatory cytokines and forskolin, a cAMP elevating agent. Previously we have shown that dexamethasone and transforming growth factor-β2 (TGF-β2) suppress sPLA2 protein synthesis and enzyme activity induced by cytokines and forskolin. The regulation of sPLA2 by pro-inflammatory cytokines suggests that the enzyme may play a role in glomerular inflammatory reactions. In order to understand the regulation of sPLA2 in more detail, we investigated whether dexamethasone and TGF-β2 also suppress sPLA2 mRNA after its induction by either interleukin-1β (IL-1β) or forskolin. We found that IL-1β-induced sPLA2 mRNA in rat mesangial cells is not down-regulated by pretreatment of the cells with dexamethasone, even at a concentration of 10 μM, which dramatically decreases sPLA2 protein levels and activity. Metabolic labelling experiments indicated that the decreased sPLA2 levels under these conditions can be explained by inhibition of the rate of sPLA2 synthesis from the elevated mRNA levels. In contrast, the forskolin-induced elevation of sPLA2 mRNA is inhibited by dexamethasone in a concentration-dependent manner. Likewise, TGF-β2 inhibits the elevation of sPLA2 mRNAs induced by either IL-1β or forskolin. The decrease in sPLA2 mRNA caused by TGF-β2 corresponds with the decrease in sPLA2 enzyme levels and activity. These data suggest that cytokine- and forskolin-induced sPLA2 expression is tightly controlled via both transcriptional and post-transcriptional mechanisms. Furthermore, we show that pretreatment of mesangial cells with epidermal growth factor prior to stimulation with IL-1β or forskolin had no suppressing effect on sPLA2 levels or enzyme activity, as has been reported previously for osteoblasts.


1990 ◽  
Vol 270 (1) ◽  
pp. 269-271 ◽  
Author(s):  
J Pfeilschifter ◽  
W Pignat ◽  
J Leighton ◽  
F Märki ◽  
K Vosbeck ◽  
...  

Treatment of rat glomerular mesangial cells with transforming growth factor beta 2 (TGF beta 2) stimulates prostaglandin E2 (PGE2) synthesis. Actinomycin D, cycloheximide and diclofenac attenuate the TGF beta 2-induced PGE2 formation. As shown previously, two proinflammatory cytokines, interleukin 1 beta (IL-1 beta) and tumour necrosis factor alpha (TNF alpha), are potent stimuli for PGE2 and phospholipase A2 secretion from mesangial cells. We report here that, whereas TGF beta 2 potentiates the IL-1 β- and TNF alpha-evoked PGE2 production, it strongly inhibits the phospholipase A2 secretion induced by both cytokines. In addition, the inhibitory effect of TGF beta 2 on phospholipase A2 secretion is not due to the augmented PGE2 formation.


1989 ◽  
Vol 86 (7) ◽  
pp. 2369-2373 ◽  
Author(s):  
F. Cozzolino ◽  
A. Rubartelli ◽  
D. Aldinucci ◽  
R. Sitia ◽  
M. Torcia ◽  
...  

1990 ◽  
Vol 38 (2) ◽  
pp. 249-257 ◽  
Author(s):  
Christian Ruef ◽  
Klemens Budde ◽  
Jill Lacy ◽  
Wolfgang Northemann ◽  
Matthias Baumann ◽  
...  

1994 ◽  
Vol 269 (31) ◽  
pp. 20060-20066 ◽  
Author(s):  
K. Hashimoto ◽  
S. Higashiyama ◽  
H. Asada ◽  
E. Hashimura ◽  
T. Kobayashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document